Praxis Precision Medicines I
PRAX·Stocks·Pharmaceuticals Major·United States·Nasdaq·USD
Price
$295.60
Today
+3.0%
YTD
+0.6%
About
Serving American customers, Praxis Precision Medicines is a clinical-stage biopharmaceutical company primarily engaged in the development of therapies for central nervous system disorders. Founded in 2015, the firm has its headquarters in Cambridge, Massachusetts, and trades on the NASDAQ GS under the ticker PRAX. Follow the PRAX price chart on eToro for instant updates.
Price chart
Closing price history for PRAX (1D candles).
Open positions
Current open positions for this instrument from your live portfolio.
Open positions
0
Unrealized return
+0.0%
No open positions exist for this instrument at the moment.
Financial insights
Valuation
P/E (TTM)-22.83
P/S (TTM)0.00
P/B (TTM)6.15
Market cap$8.25B
Cap tierMid-cap
Industry avg P/E-7.37
Profitability
Gross margin97.87%
EBIT margin0.00%
Net margin-786.27%
ROE-38.86%
ROA-36.80%
Earnings & Revenue
Revenue (TTM)$0.00
Revenue growth (1Y)-100.0%
EPS (TTM)-$12.94
Free cash flow$-305.55M
Total debt$1.09M
Dividends & Risk
Dividend rate$0.00
Dividend yield0.00%
Beta (5Y)1.00
Employees168
Next earnings9 Nov '26
Trade history
Closed trades
0
Realized return
+0.0%
No stored closed trades exist for this instrument yet.